Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS2 | P35228 | 6/20 | 0.41 |
| ▸ | NOS1 | P29475 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
| ▸ | NOS3 | P29474 | 3/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7854852 | 0.98 | ALDH1A1 (0.41) | NOS2NOS1ALDH1A1TAAR1NOS3 | |
| SCHEMBL7854308 | 0.98 | ALDH1A1 (0.41) | NOS2NOS1ALDH1A1TAAR1NOS3 | |
| SCHEMBL7846606 | 0.98 | ALDH1A1 (0.41) | NOS2NOS1ALDH1A1TAAR1NOS3 | |
| SCHEMBL7857240 | 0.98 | ALDH1A1 (0.41) | NOS2NOS1ALDH1A1TAAR1NOS3 | |
| SCHEMBL7651855 | 0.98 | ALDH1A1 (0.41) | NOS2NOS1ALDH1A1TAAR1NOS3 | |
| SCHEMBL7856874 | 0.98 | ALDH1A1 (0.41) | NOS2NOS1ALDH1A1TAAR1NOS3 | |
| SCHEMBL28581955 | 0.96 | NOS2 (0.45) | NOS2NOS1ALDH1A1TAAR1NOS3 | |
| SCHEMBL28581953 | 0.96 | NOS2 (0.45) | NOS2NOS1ALDH1A1TAAR1NOS3 | |
| SCHEMBL10616856 | 0.95 | NOS2 (0.44) | NOS2NOS1ALDH1A1TAAR1NOS3 | |
| SCHEMBL10491961 | 0.86 | ALDH1A1 (0.34) | NOS2NOS1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108368154-B | Polypeptides | 诺维信公司 | 2023-02-03 | — | — | CN | disclosed |
| CN-115210371-A | Carbohydrate binding module variants | 诺维信公司 | 2022-10-18 | — | — | CN | disclosed |
| CN-115011417-A | Detergent compositions comprising bacterial mannanase | AB酶股份有限公司 | 2022-09-06 | — | — | CN | disclosed |
| CN-114929848-A | Stable liquid boron-free enzyme compositions | 诺维信公司 | 2022-08-19 | — | — | CN | disclosed |
| CN-114846128-A | Cleaning compositions comprising disperse protein VIII | 汉高股份有限及两合公司 | 2022-08-02 | — | — | CN | disclosed |
| CN-114829564-A | Cleaning compositions comprising dispersible protein and carbohydrase | 汉高股份有限及两合公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-114829563-A | Cleaning compositions comprising dispersed protein IX | 汉高股份有限及两合公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-114829562-A | Cleaning compositions comprising dispersible protein VI | 汉高股份有限及两合公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-114634921-A | Alpha-amylase variants and polynucleotides encoding same | 诺维信公司 | 2022-06-17 | — | — | CN | disclosed |
| CN-110709498-B | Detergent compositions comprising bacterial mannanase | AB酶股份有限公司 | 2022-01-14 | — | — | CN | disclosed |
| CN-110869483-A | Detergent compositions containing enzymes | 罗地亚经营管理公司 | 2020-03-06 | — | — | CN | disclosed |
| CN-110777016-A | Detergent compositions with lipase variants | 诺维信公司 | 2020-02-11 | — | — | CN | disclosed |
| CN-110709498-A | Detergent compositions comprising bacterial mannanase | AB酶股份有限公司 | 2020-01-17 | — | — | CN | disclosed |
| WO-2014090918-A1 | PROCESS FOR THE ENANTIOMERIC ENRICHMENT OF DIARYLOXAZOLINE DERIVATIVES | NOVARTIS AG (CH) | 2014-06-19 | — | — | WO | disclosed |
| US-6670307-B2 | Such as 2-(2,6-difluorophenyl)-4-(4-(2-ethoxypyridin-5-yl) phenyl)oxazoline; for administration to livestock | HOECHST SCHERING AGREVO GMBH (DE) | 2003-12-30 | — | — | US | disclosed |
| EP-1087967-B1 | 1,3-OXAZOLINE AND 1,3-THIAZOLINE DERIVATIVES, METHOD FOR PRODUCING THE SAME AND THEIR USE AS PESTICIDES | BAYER CROPSCIENCE GMBH (DE) | 2003-10-22 | — | — | EP | disclosed |
| US-20020068828-A1 | 1,3-oxazoline and 1,3-thiazoline derivatives, their preparation, and their use as pesticides | BAYER CROPSCIENCE AG (DE) | 2002-06-06 | — | — | US | disclosed |
| US-6265350-B1 | CONTROLLING HARMFUL FUNGI, INSECTS, ACARINA, MOLLUSKS AND NEMATODES | HOECHST SCHERING AGREVO GMBH (DE) | 2001-07-24 | — | — | US | disclosed |
| EP-1087967-A1 | 1,3-OXAZOLINE AND 1,3-THIAZOLINE DERIVATIVES, METHOD FOR PRODUCING THE SAME AND THEIR USE AS PESTICIDES | Aventis CropScience GmbH (DE) | 2001-04-04 | — | — | EP | disclosed |
| WO-1999065901-A1 | 1,3-OXAZOLINE AND 1,3-THIAZOLINE DERIVATIVES, METHOD FOR PRODUCING THE SAME AND THEIR USE AS PESTICIDES | AVENTIS CROPSCIENCE GMBH (DE) | 1999-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020068828-A1 | 1,3-oxazoline and 1,3-thiazoline derivatives, their preparation, and their use as pesticides | MT-CO1, OXA1L, MT-CO3 | NOS2 1343/4885NOS1 513/4885ALDH1A1 127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.